These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16410303)

  • 1. Haplotype insufficiency for suppressor of cytokine signaling-2 enhances intestinal growth and promotes polyp formation in growth hormone-transgenic mice.
    Michaylira CZ; Ramocki NM; Simmons JG; Tanner CK; McNaughton KK; Woosley JT; Greenhalgh CJ; Lund PK
    Endocrinology; 2006 Apr; 147(4):1632-41. PubMed ID: 16410303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppressor of cytokine signaling-2 limits intestinal growth and enterotrophic actions of IGF-I in vivo.
    Michaylira CZ; Simmons JG; Ramocki NM; Scull BP; McNaughton KK; Fuller CR; Lund PK
    Am J Physiol Gastrointest Liver Physiol; 2006 Sep; 291(3):G472-81. PubMed ID: 16574995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppressor of cytokine signaling-2 deficiency induces molecular and metabolic changes that partially overlap with growth hormone-dependent effects.
    Rico-Bautista E; Greenhalgh CJ; Tollet-Egnell P; Hilton DJ; Alexander WS; Norstedt G; Flores-Morales A
    Mol Endocrinol; 2005 Mar; 19(3):781-93. PubMed ID: 15563548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOCS2 mediates the cross talk between androgen and growth hormone signaling in prostate cancer.
    Iglesias-Gato D; Chuan YC; Wikström P; Augsten S; Jiang N; Niu Y; Seipel A; Danneman D; Vermeij M; Fernandez-Perez L; Jenster G; Egevad L; Norstedt G; Flores-Morales A
    Carcinogenesis; 2014 Jan; 35(1):24-33. PubMed ID: 24031028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppressor of cytokine signaling-2 modulates the fibrogenic actions of GH and IGF-I in intestinal mesenchymal cells.
    Fruchtman S; Simmons JG; Michaylira CZ; Miller ME; Greenhalgh CJ; Ney DM; Lund PK
    Am J Physiol Gastrointest Liver Physiol; 2005 Aug; 289(2):G342-50. PubMed ID: 15831713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressor of cytokine signaling 2 (
    Dobie R; MacRae VE; Pass C; Milne EM; Ahmed SF; Farquharson C
    Dis Model Mech; 2018 Jan; 11(1):. PubMed ID: 29343614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppressor of cytokine signaling-2: a growth hormone-inducible inhibitor of intestinal epithelial cell proliferation.
    Miller ME; Michaylira CZ; Simmons JG; Ney DM; Dahly EM; Heath JK; Lund PK
    Gastroenterology; 2004 Aug; 127(2):570-81. PubMed ID: 15300589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced survival and mucosal repair after dextran sodium sulfate-induced colitis in transgenic mice that overexpress growth hormone.
    Williams KL; Fuller CR; Dieleman LA; DaCosta CM; Haldeman KM; Sartor RB; Lund PK
    Gastroenterology; 2001 Mar; 120(4):925-37. PubMed ID: 11231946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased linear bone growth by GH in the absence of SOCS2 is independent of IGF-1.
    Dobie R; Ahmed SF; Staines KA; Pass C; Jasim S; MacRae VE; Farquharson C
    J Cell Physiol; 2015 Nov; 230(11):2796-806. PubMed ID: 25833299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of SOCS2 on neuronal differentiation and morphology.
    Scott HJ; Stebbing MJ; Walters CE; McLenachan S; Ransome MI; Nichols NR; Turnley AM
    Brain Res; 2006 Jan; 1067(1):138-45. PubMed ID: 16360125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A designed cell-penetrating human SOCS2 protein suppresses GH-dependent cancer cell proliferation.
    Miyamoto A; Masuhiro Y; Seki T; Hanazawa S; Shiba H
    Biosci Biotechnol Biochem; 2019 Feb; 83(2):300-308. PubMed ID: 30343638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 17β-Estradiol positively modulates growth hormone signaling through the reduction of SOCS2 negative feedback in human osteoblasts.
    Bolamperti S; Mrak E; Moro G; Sirtori P; Fraschini G; Guidobono F; Rubinacci A; Villa I
    Bone; 2013 Jul; 55(1):84-92. PubMed ID: 23567159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GH/STAT5 signaling during the growth period in livers of mice overexpressing GH.
    Martinez CS; Piazza VG; Díaz ME; Boparai RK; Arum O; Ramírez MC; González L; Becú-Villalobos D; Bartke A; Turyn D; Miquet JG; Sotelo AI
    J Mol Endocrinol; 2015 Apr; 54(2):171-84. PubMed ID: 25691498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone signaling and hippocampal neurogenesis: insights from genetic models.
    Ransome MI; Turnley AM
    Hippocampus; 2008; 18(10):1034-50. PubMed ID: 18566962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth-hormone-induced signal transducer and activator of transcription 5 signaling causes gigantism, inflammation, and premature death but protects mice from aggressive liver cancer.
    Friedbichler K; Themanns M; Mueller KM; Schlederer M; Kornfeld JW; Terracciano LM; Kozlov AV; Haindl S; Kenner L; Kolbe T; Mueller M; Snibson KJ; Heim MH; Moriggl R
    Hepatology; 2012 Mar; 55(3):941-52. PubMed ID: 22031092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal IGF-I overexpression: paracrine effects in the intestine, distinct from endocrine actions.
    Williams KL; Fuller CR; Fagin J; Lund PK
    Am J Physiol Gastrointest Liver Physiol; 2002 Oct; 283(4):G875-85. PubMed ID: 12223347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SOCS2 negatively regulates growth hormone action in vitro and in vivo.
    Greenhalgh CJ; Rico-Bautista E; Lorentzon M; Thaus AL; Morgan PO; Willson TA; Zervoudakis P; Metcalf D; Street I; Nicola NA; Nash AD; Fabri LJ; Norstedt G; Ohlsson C; Flores-Morales A; Alexander WS; Hilton DJ
    J Clin Invest; 2005 Feb; 115(2):397-406. PubMed ID: 15690087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in the expression of suppressor of cytokine signalling (SOCS) 2 in the colonic mucosa of acromegalic patients are associated with hyperplastic polyps.
    Bogazzi F; Ultimieri F; Raggi F; Russo D; Costa A; Marciano E; Bartalena L; Martino E
    Clin Endocrinol (Oxf); 2009 Jun; 70(6):898-906. PubMed ID: 18844680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopaminergic activity and behaviour in SOCS2 transgenic mice: Revealing a potential drug target for schizophrenia.
    Ratnayake U; Basrai HS; Turnley AM; van den Buuse M
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jan; 56():247-53. PubMed ID: 25283341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic growth hormone resistance during sepsis is associated with increased suppressors of cytokine signaling expression and impaired growth hormone signaling.
    Yumet G; Shumate ML; Bryant DP; Lang CH; Cooney RN
    Crit Care Med; 2006 May; 34(5):1420-7. PubMed ID: 16540952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.